Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-022845

Chief Financial Officer sold 34,972 shares at $60.19 ($2,104,965)

  • Chief Financial Officer acquired 34,972 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Prasad Raju Chief Financial Officer 2026-01-22 Option exercise 10b5-1 +34,972 $45.15 $1,578,986 41,739 D
Prasad Raju Chief Financial Officer 2026-01-22 Sale 10b5-1 −34,972 $60.19 $2,104,965 6,767 D
Derivatives
Prasad Raju Chief Financial Officer 2026-01-22 Option exercise · Stock Option (Right to Buy) 10b5-1 −34,972 41,667 D
Open-market sales · 34,972 sh · avg $60.19 · $2,104,965
Loading xslF345X05/ownership.xml…